Interpace Biosciences, Inc. (IDXG)
1.95
-0.05
(-2.50%)
USD |
OTCM |
May 08, 16:00
Interpace Biosciences Shareholders Equity (Quarterly) : 22.36M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodesix, Inc. | 9.132M |
| FONAR Corp. | 176.93M |
| Thermo Fisher Scientific, Inc. | 51.93B |
| Innovative MedTech, Inc. | -1.053M |
| Meridian Holdings, Inc. (California) | -2.206M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.84M |
| Total Liabilities (Quarterly) | 11.48M |
| Debt to Equity Ratio | 0.0529 |
| Current Ratio | 1.94 |
| Net Debt Paydown Yield | 22.02% |